| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,262 |
12,126 |
$578K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,312 |
1,171 |
$35K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,606 |
1,384 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,478 |
2,209 |
$28K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
826 |
716 |
$27K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,945 |
1,447 |
$25K |
| 80305 |
|
2,281 |
1,417 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
270 |
211 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
387 |
330 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
40 |
38 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
116 |
102 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
32 |
29 |
$1K |
| 90633 |
|
40 |
36 |
$808.47 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
40 |
38 |
$451.80 |
| 36415 |
Collection of venous blood by venipuncture |
418 |
361 |
$272.00 |
| 81003 |
|
403 |
343 |
$45.43 |
| S5001 |
Prescription drug, brand name |
25 |
25 |
$25.32 |